SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000019617-24-000145
Filing Date
2024-01-25
Accepted
2024-01-25 11:10:47
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 FILING REVANCE THERAPEUTICS, INC. Revance_Therapeutics_Inc.h.htm SC 13G/A 88193
  Complete submission text file 0000019617-24-000145.txt   90122
Mailing Address 383 MADISON AVENUE NEW YORK NY 10017
Business Address 383 MADISON AVENUE NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

IRS No.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks
(CF Office: 02 Finance)

Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Subject) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88023
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)